Experts discuss clinical management of new infectious diseases
A conference was held in Hanoi on September 12 to discuss the clinical management of acute respiratory infection and newly emerging communicable diseases.
Associate Professor, Dr. Luong Ngoc Khue, head of the Department of Medical Examination and Treatment addresses the event (Photo: //suckhoedoisong.vn)
Hanoi (VNA) – A conference was held in Hanoi on September12 to discuss the clinical management of acute respiratory infection and newlyemerging communicable diseases.
Addressing the event, Associate Professor, Dr. Luong Ngoc Khue, head ofthe Department of Medical Examination and Treatment, said that Vietnam is a hotspot of newly emerging communicable diseases with high risks of becoming anepidemic.
In recent years, Vietnam has countered SARS, influenza A virus subtypesH1N1 and H5N1, foot-and-mount disease, and measles, and it is battling denguefever. The fatality ratio from the diseases was estimated at 30 percent in2010.
Currently, patients have enjoyed easy and quick access to health careservices. However, health care facilities have been in frequent overloadconditions, especially central hospitals.
Khue said that the improvement of capacity in clinical management of infectiousdiseases is a priority of the Ministry of Health. He also pointed to variouspolicies and projects in the field.
Since 2012, with the support of the World Health Organisation (WHO), theDepartment of Medical Examination and Treatment has evaluated the capacity anddemand for training in the clinical management of acute respiratory infection,as well as in building training programmes and translating the guidelines ofthe WHO.
At the event, participants also assessed the real situation and defined orientationsfor the management of the clinical management of acute respiratory infectionand newly-emerging communicable diseases in Vietnam. They also shared theirreal experience in the field. - VNA
New medical graduates could be required to work for three to five years at healthcare centres in outlying regions to meet a critical lack of doctors and help improve healthcare services there.
APEC health officials are expected to have a hectic day in Ho Chi Minh City on August 3 with two policy dialogues and one meeting of the Health Working Group.
As many as 180 international and Vietnamese bio-safety experts, professionals and practitioners are discussing bio-risk, bio-preparedness, and bio-terrorism at the 12th Asia-Pacific Biosafety Association (A-PBA) Conference that opened in Ho Chi Minh City on August 24.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
Associate Professor, Dr. Luong Ngoc Khue, head of the Department of Medical Examination and Treatment addresses the event (Photo: //suckhoedoisong.vn) 
